Androgen production by monkey luteal cell subpopulations at different stages of the menstrual cycle

Sheryl L. Sanders, Richard Stouffer, John D. Brannian

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    Androgens produced by the primate corpus luteum (CL) serve as precursors for estrogen synthesis; moreover, detection of androgen receptors in luteal tissue suggests a regulatory role within the CL. To determine the cellular source(s) and agonist regulation of androgen production during the lifespan of the primate CL, luteal tissues were collected from rhesus monkeys in the early (days 3-5 post-LH surge), mid (days 7-8), mid-late (days 11-12), and late (days 14-15) luteal phase of the menstrual cycle. Collagenase-dispersed cells (i.e. mixed cells) were analyzed by flow cytometry based on light scatter properties and sorted into populations of small (≤15 μm) and large (>20 μm) luteal cells. Cells (n = 4 animals/stage) were incubated in Ham's F-10 and 0.1% BSA for 3 h at 37 C with or without hCG (100 ng/mL), PGE2 (14 μmol/L), or dibutyryl cAMP (dbcAMP; 5 mmol/L), and androstenedione (A4) and testosterone were measured. Basal A4 production by large cells was markedly higher (P <0.05) than that by small cells (e.g. mid-late luteal phase, 821 ± 188 vs. 69 ± 25 pg/mL · 5 x 104 cells/3 h; mean ± SEM), whereas that by mixed cells was intermediate (317 ± 205 pg/mL). In the early luteal phase, hCG stimulated A4 synthesis by mixed (1.6-fold; P <0.05) and large (3.1-fold; P <0.05) luteal cells, but not by small cells (1.3-fold). By the mid-late luteal phase, hCG did not increase A4 production by any cell type, although hCG responsiveness returned to large cells (2.0-fold increase; P <0.05) by the late luteal phase. PGE2 responsiveness by cell types was similar to that of hCG, except large cell responsiveness did not return in the late luteal phase. In all cell types, dbcAMP stimulated the largest increase in A4 levels; in the mid-late luteal phase, small and large cells responded to dbcAMP with 8.2- and 3.0-fold increases (P <0.05) in A4 production, respectively. When luteal cells were incubated with the steroidogenic substrates, 17α-hydroxyprogesterone or 17α- hydroxypregnenolone (1 μmol/L), large cells produced much more (P <0.05) A4, testosterone, estrone, and estradiol than small cells. Both substrates elicited similar patterns of androgen production, with A4 synthesis predominant in all luteal cell types. Thus, cell subpopulations in the primate CL can be distinguished by their ability to produce androgen and estrogen. Changes in agonist-responsive androgen production may influence the local steroid milieu and function of the CL during the menstrual cycle.

    Original languageEnglish (US)
    Pages (from-to)591-596
    Number of pages6
    JournalJournal of Clinical Endocrinology and Metabolism
    Volume81
    Issue number2
    DOIs
    StatePublished - 1996

    Fingerprint

    Luteal Cells
    Menstrual Cycle
    Androgens
    Haplorhini
    Luteal Phase
    Corpus Luteum
    Dinoprostone
    Testosterone
    Estrogens
    17-alpha-Hydroxypregnenolone
    Tissue
    17-alpha-Hydroxyprogesterone
    Flow cytometry
    Androstenedione
    Estrone
    Androgen Receptors
    Collagenases
    Substrates
    Primates
    Estradiol

    ASJC Scopus subject areas

    • Biochemistry
    • Endocrinology, Diabetes and Metabolism

    Cite this

    Androgen production by monkey luteal cell subpopulations at different stages of the menstrual cycle. / Sanders, Sheryl L.; Stouffer, Richard; Brannian, John D.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 81, No. 2, 1996, p. 591-596.

    Research output: Contribution to journalArticle

    @article{151ec02e8b1a41098f983fe18816ce1c,
    title = "Androgen production by monkey luteal cell subpopulations at different stages of the menstrual cycle",
    abstract = "Androgens produced by the primate corpus luteum (CL) serve as precursors for estrogen synthesis; moreover, detection of androgen receptors in luteal tissue suggests a regulatory role within the CL. To determine the cellular source(s) and agonist regulation of androgen production during the lifespan of the primate CL, luteal tissues were collected from rhesus monkeys in the early (days 3-5 post-LH surge), mid (days 7-8), mid-late (days 11-12), and late (days 14-15) luteal phase of the menstrual cycle. Collagenase-dispersed cells (i.e. mixed cells) were analyzed by flow cytometry based on light scatter properties and sorted into populations of small (≤15 μm) and large (>20 μm) luteal cells. Cells (n = 4 animals/stage) were incubated in Ham's F-10 and 0.1{\%} BSA for 3 h at 37 C with or without hCG (100 ng/mL), PGE2 (14 μmol/L), or dibutyryl cAMP (dbcAMP; 5 mmol/L), and androstenedione (A4) and testosterone were measured. Basal A4 production by large cells was markedly higher (P <0.05) than that by small cells (e.g. mid-late luteal phase, 821 ± 188 vs. 69 ± 25 pg/mL · 5 x 104 cells/3 h; mean ± SEM), whereas that by mixed cells was intermediate (317 ± 205 pg/mL). In the early luteal phase, hCG stimulated A4 synthesis by mixed (1.6-fold; P <0.05) and large (3.1-fold; P <0.05) luteal cells, but not by small cells (1.3-fold). By the mid-late luteal phase, hCG did not increase A4 production by any cell type, although hCG responsiveness returned to large cells (2.0-fold increase; P <0.05) by the late luteal phase. PGE2 responsiveness by cell types was similar to that of hCG, except large cell responsiveness did not return in the late luteal phase. In all cell types, dbcAMP stimulated the largest increase in A4 levels; in the mid-late luteal phase, small and large cells responded to dbcAMP with 8.2- and 3.0-fold increases (P <0.05) in A4 production, respectively. When luteal cells were incubated with the steroidogenic substrates, 17α-hydroxyprogesterone or 17α- hydroxypregnenolone (1 μmol/L), large cells produced much more (P <0.05) A4, testosterone, estrone, and estradiol than small cells. Both substrates elicited similar patterns of androgen production, with A4 synthesis predominant in all luteal cell types. Thus, cell subpopulations in the primate CL can be distinguished by their ability to produce androgen and estrogen. Changes in agonist-responsive androgen production may influence the local steroid milieu and function of the CL during the menstrual cycle.",
    author = "Sanders, {Sheryl L.} and Richard Stouffer and Brannian, {John D.}",
    year = "1996",
    doi = "10.1210/jc.81.2.591",
    language = "English (US)",
    volume = "81",
    pages = "591--596",
    journal = "Journal of Clinical Endocrinology and Metabolism",
    issn = "0021-972X",
    publisher = "The Endocrine Society",
    number = "2",

    }

    TY - JOUR

    T1 - Androgen production by monkey luteal cell subpopulations at different stages of the menstrual cycle

    AU - Sanders, Sheryl L.

    AU - Stouffer, Richard

    AU - Brannian, John D.

    PY - 1996

    Y1 - 1996

    N2 - Androgens produced by the primate corpus luteum (CL) serve as precursors for estrogen synthesis; moreover, detection of androgen receptors in luteal tissue suggests a regulatory role within the CL. To determine the cellular source(s) and agonist regulation of androgen production during the lifespan of the primate CL, luteal tissues were collected from rhesus monkeys in the early (days 3-5 post-LH surge), mid (days 7-8), mid-late (days 11-12), and late (days 14-15) luteal phase of the menstrual cycle. Collagenase-dispersed cells (i.e. mixed cells) were analyzed by flow cytometry based on light scatter properties and sorted into populations of small (≤15 μm) and large (>20 μm) luteal cells. Cells (n = 4 animals/stage) were incubated in Ham's F-10 and 0.1% BSA for 3 h at 37 C with or without hCG (100 ng/mL), PGE2 (14 μmol/L), or dibutyryl cAMP (dbcAMP; 5 mmol/L), and androstenedione (A4) and testosterone were measured. Basal A4 production by large cells was markedly higher (P <0.05) than that by small cells (e.g. mid-late luteal phase, 821 ± 188 vs. 69 ± 25 pg/mL · 5 x 104 cells/3 h; mean ± SEM), whereas that by mixed cells was intermediate (317 ± 205 pg/mL). In the early luteal phase, hCG stimulated A4 synthesis by mixed (1.6-fold; P <0.05) and large (3.1-fold; P <0.05) luteal cells, but not by small cells (1.3-fold). By the mid-late luteal phase, hCG did not increase A4 production by any cell type, although hCG responsiveness returned to large cells (2.0-fold increase; P <0.05) by the late luteal phase. PGE2 responsiveness by cell types was similar to that of hCG, except large cell responsiveness did not return in the late luteal phase. In all cell types, dbcAMP stimulated the largest increase in A4 levels; in the mid-late luteal phase, small and large cells responded to dbcAMP with 8.2- and 3.0-fold increases (P <0.05) in A4 production, respectively. When luteal cells were incubated with the steroidogenic substrates, 17α-hydroxyprogesterone or 17α- hydroxypregnenolone (1 μmol/L), large cells produced much more (P <0.05) A4, testosterone, estrone, and estradiol than small cells. Both substrates elicited similar patterns of androgen production, with A4 synthesis predominant in all luteal cell types. Thus, cell subpopulations in the primate CL can be distinguished by their ability to produce androgen and estrogen. Changes in agonist-responsive androgen production may influence the local steroid milieu and function of the CL during the menstrual cycle.

    AB - Androgens produced by the primate corpus luteum (CL) serve as precursors for estrogen synthesis; moreover, detection of androgen receptors in luteal tissue suggests a regulatory role within the CL. To determine the cellular source(s) and agonist regulation of androgen production during the lifespan of the primate CL, luteal tissues were collected from rhesus monkeys in the early (days 3-5 post-LH surge), mid (days 7-8), mid-late (days 11-12), and late (days 14-15) luteal phase of the menstrual cycle. Collagenase-dispersed cells (i.e. mixed cells) were analyzed by flow cytometry based on light scatter properties and sorted into populations of small (≤15 μm) and large (>20 μm) luteal cells. Cells (n = 4 animals/stage) were incubated in Ham's F-10 and 0.1% BSA for 3 h at 37 C with or without hCG (100 ng/mL), PGE2 (14 μmol/L), or dibutyryl cAMP (dbcAMP; 5 mmol/L), and androstenedione (A4) and testosterone were measured. Basal A4 production by large cells was markedly higher (P <0.05) than that by small cells (e.g. mid-late luteal phase, 821 ± 188 vs. 69 ± 25 pg/mL · 5 x 104 cells/3 h; mean ± SEM), whereas that by mixed cells was intermediate (317 ± 205 pg/mL). In the early luteal phase, hCG stimulated A4 synthesis by mixed (1.6-fold; P <0.05) and large (3.1-fold; P <0.05) luteal cells, but not by small cells (1.3-fold). By the mid-late luteal phase, hCG did not increase A4 production by any cell type, although hCG responsiveness returned to large cells (2.0-fold increase; P <0.05) by the late luteal phase. PGE2 responsiveness by cell types was similar to that of hCG, except large cell responsiveness did not return in the late luteal phase. In all cell types, dbcAMP stimulated the largest increase in A4 levels; in the mid-late luteal phase, small and large cells responded to dbcAMP with 8.2- and 3.0-fold increases (P <0.05) in A4 production, respectively. When luteal cells were incubated with the steroidogenic substrates, 17α-hydroxyprogesterone or 17α- hydroxypregnenolone (1 μmol/L), large cells produced much more (P <0.05) A4, testosterone, estrone, and estradiol than small cells. Both substrates elicited similar patterns of androgen production, with A4 synthesis predominant in all luteal cell types. Thus, cell subpopulations in the primate CL can be distinguished by their ability to produce androgen and estrogen. Changes in agonist-responsive androgen production may influence the local steroid milieu and function of the CL during the menstrual cycle.

    UR - http://www.scopus.com/inward/record.url?scp=0030062748&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0030062748&partnerID=8YFLogxK

    U2 - 10.1210/jc.81.2.591

    DO - 10.1210/jc.81.2.591

    M3 - Article

    C2 - 8636273

    AN - SCOPUS:0030062748

    VL - 81

    SP - 591

    EP - 596

    JO - Journal of Clinical Endocrinology and Metabolism

    JF - Journal of Clinical Endocrinology and Metabolism

    SN - 0021-972X

    IS - 2

    ER -